Arkolith/Insider Trading/TCRX/Form 4

Barberich Timothy J

DirectorTScan Therapeutics, Inc. (TCRX) · full profile →Form 4 · filed Dec 21, 2023
Net Buying
Open-Market Buys
$143K
Open-Market Sells
$0
Net Open-Market Flow
$143K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 19, 2023Buy(P)317$4.97$2K67K
Dec 18, 2023Buy(P)29K$4.89$141K67K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-072291) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML